Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression

Annals of Oncology

Volumn 12, Issue 11, 2001, Pages 1561-1566

  Kao, A ^a   Shiun, S C ^a   Hsu, N Y ^a   Sun, S S ^a   Lee, C C ^a   Lin, C C ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chemotherapy; Multidrug resistance related protein; P glycoprotein; Small cell lung cancer; Technetium 99m methoxyisobutylisonitrile

Indexed keywords

CISPLATIN; ETOPOSIDE; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NODULE; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RANDOMIZATION; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE SECTION; TREATMENT OUTCOME; TUMOR BIOPSY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PROGNOSIS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035692579     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013133801173     Document Type: Article

References (30)

1. Chemotherapy of small-cell lung cancer
2. Chemotherapy of small-cell carcinoma of the lung
3. Small-cell carcinoma of the lung
4. The clinical role of MDR1 gene expression in human lung cancer
5. Sequential coexpression of the multidrug resistance gene MRP and mdr1 and their products in products in VP-16 (Etoposide)-selected H69 small-cell lung cancer cells
6. Multidrug resistance associated protein (MRP) gene expression in human lung cancer
7. Mechanism of drug resistance in lung cancer cells
8. Mechanisms of drug resistance
9. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex
10. Visualization of multidrug resistance in vivo
11. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes
12. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein
13. Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile
14. Tracer imaging in lung cancer
15. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small-cell lung cancer
16. Technetium-99m methoxyisobutylisonitrile chest imaging of small-cell lung carcinoma: Relation to patient prognosis and chemotherapy response - A preliminary report
17. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small-cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography
18. Assessment of tumour necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m MIBI imaging: Comparison with CT scan
19. Toxicity and response criteria of the Eastern Cooperative Oncology Group
20. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer
21. Immunohistochemical detection of DNA topoisomerases 11α, p-glycoprotein and multidrug resistance protein (MRP) in non-small-cell lung cancer
22. Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas
23. The use of nitrogen mustards in the palliative treatment of cancer
24. Lung cancer and mesothelioma
25. Multidrug resistance genes (MRP) and MDR1 expression in small-cell lung cancer xenografts: Relationship with response to chemotherapy
26. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs
27. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblast
28. Noncardiac applications of hexakis(alkylsionitrile)technetium-99m complexes
29. Expression of the MRP and MDR1 multidrug resistance genes in small-cell lung cancer
30. Semi-quantitative assessment of 99Tcm-sestamibi uptake in lung cancer: Relationship with clinical response to chemotherapy